|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0016360,
umls-concept:C0023413,
umls-concept:C0029246,
umls-concept:C0034656,
umls-concept:C0035168,
umls-concept:C0087111,
umls-concept:C0205179,
umls-concept:C0239307,
umls-concept:C0282461,
umls-concept:C0332174,
umls-concept:C0521362,
umls-concept:C0574032,
umls-concept:C1257890,
umls-concept:C1442162,
umls-concept:C1511237,
umls-concept:C1527249,
umls-concept:C1550436,
umls-concept:C1550718,
umls-concept:C1705509,
umls-concept:C2603343
|
|
pubmed:issue |
20
|
|
pubmed:dateCreated |
2003-10-10
|
|
pubmed:abstractText |
This trial was conducted to determine whether high-dose fluorouracil (FU) given as a weekly 24-hour infusion is more active than bolus FU + leucovorin (LV), and whether high-dose infusional FU can be modulated by LV.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BaronBB,
pubmed-author:BokemeyerCC,
pubmed-author:BurkhardOO,
pubmed-author:CouvreurM LML,
pubmed-author:El-SerafiMM,
pubmed-author:European Organization of Research and Treatment of Cancer...,
pubmed-author:KöhneC-HCH,
pubmed-author:KleebergCC,
pubmed-author:LangenbuchTT,
pubmed-author:LichnitserMM,
pubmed-author:LorenzMM,
pubmed-author:PENGS YSY,
pubmed-author:RückleHH,
pubmed-author:RidwelskiKK,
pubmed-author:SchöffskiPP,
pubmed-author:ScheithauerWW,
pubmed-author:SchmollH JHJ,
pubmed-author:SouchonRR,
pubmed-author:VoigtmannRR,
pubmed-author:WeissUU,
pubmed-author:WilkBB
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3721-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12963704-Adult,
pubmed-meshheading:12963704-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12963704-Colorectal Neoplasms,
pubmed-meshheading:12963704-Drug Administration Schedule,
pubmed-meshheading:12963704-Female,
pubmed-meshheading:12963704-Fluorouracil,
pubmed-meshheading:12963704-Humans,
pubmed-meshheading:12963704-Infusions, Intravenous,
pubmed-meshheading:12963704-Injections, Intravenous,
pubmed-meshheading:12963704-Leucovorin,
pubmed-meshheading:12963704-Male,
pubmed-meshheading:12963704-Middle Aged,
pubmed-meshheading:12963704-Neoplasm Metastasis,
pubmed-meshheading:12963704-Quality of Life,
pubmed-meshheading:12963704-Survival Rate,
pubmed-meshheading:12963704-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.
|
|
pubmed:affiliation |
Department og Internal Medicine I, University of Dresden, Dresden, Germany. claus-henning.koehne@uniklinikum-dresden.de
|
|
pubmed:publicationType |
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase III
|
